Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (361-370 of 645) with videos related to

Pageof 65
Sort By:
COPD|April 8, 2020
Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose CombinationPaola Rogliani, Beatrice Ludovica Ritondo, Bartolomeo Zerillo, et al.
Pulmonary Pharmacology & Therapeutics|April 23, 2015
Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airwaysLuigino Calzetta, Mario Cazzola, Clive P Page, et al.
Respiratory Medicine|October 22, 2005
Treatments for COPDNicola A Hanania, Nicolino Ambrosino, Peter Calverley, et al.
Expert Review of Respiratory Medicine|April 15, 2026
Respiratory health in a changing environment: environment-adaptive therapies and revised dosing strategiesMario Cazzola, Raffaella Pagliar, Alfredo De Biase, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 21, 2018
New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technologyAnthony D D'Urzo, Mario Cazzola, Nicola A Hanania, et al.
Pulmonary Pharmacology & Therapeutics|April 8, 2006
Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patientsMario Cazzola, Antonio Mantero, Pierachille Santus, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|April 22, 2011
Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008Mario Cazzola, Andrea Segreti, Germano Bettoncelli, et al.
Leukemia & Lymphoma|October 30, 2004
Survivin expression in acute leukemias and myelodysplastic syndromesRosangela Invernizzi, Erica Travaglino, Monia Lunghi, et al.
International Journal of Mycobacteriology|June 1, 2016
An unusual outbreak of nontuberculous mycobacteria in hospital respiratory wards: Association with nontuberculous mycobacterial colonization of hospital water supply networkSalvatore D'Antonio, Paola Rogliani, Gregorino Paone, et al.
Respiratory Medicine|February 3, 2022
Can FeNO be a biomarker in the post-COVID-19 patients monitoring?Mauro Maniscalco, Pasquale Ambrosino, Remo Poto, et al.
Pageof 65

Showing results (361-370 of 645) with videos related to

Sort By:
Pageof 65
COPD|April 8, 2020
Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose CombinationPaola Rogliani, Beatrice Ludovica Ritondo, Bartolomeo Zerillo, et al.
Pulmonary Pharmacology & Therapeutics|April 23, 2015
Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airwaysLuigino Calzetta, Mario Cazzola, Clive P Page, et al.
Respiratory Medicine|October 22, 2005
Treatments for COPDNicola A Hanania, Nicolino Ambrosino, Peter Calverley, et al.
Expert Review of Respiratory Medicine|April 15, 2026
Respiratory health in a changing environment: environment-adaptive therapies and revised dosing strategiesMario Cazzola, Raffaella Pagliar, Alfredo De Biase, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 21, 2018
New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technologyAnthony D D'Urzo, Mario Cazzola, Nicola A Hanania, et al.
Pulmonary Pharmacology & Therapeutics|April 8, 2006
Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patientsMario Cazzola, Antonio Mantero, Pierachille Santus, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|April 22, 2011
Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008Mario Cazzola, Andrea Segreti, Germano Bettoncelli, et al.
Leukemia & Lymphoma|October 30, 2004
Survivin expression in acute leukemias and myelodysplastic syndromesRosangela Invernizzi, Erica Travaglino, Monia Lunghi, et al.
International Journal of Mycobacteriology|June 1, 2016
An unusual outbreak of nontuberculous mycobacteria in hospital respiratory wards: Association with nontuberculous mycobacterial colonization of hospital water supply networkSalvatore D'Antonio, Paola Rogliani, Gregorino Paone, et al.
Respiratory Medicine|February 3, 2022
Can FeNO be a biomarker in the post-COVID-19 patients monitoring?Mauro Maniscalco, Pasquale Ambrosino, Remo Poto, et al.
Pageof 65